FDA Inspection 756042 — Oklahoma Blood Institute Northwest

Oklahoma Blood Institute Northwest — FEI 1626218

The FDA completed an inspection of Oklahoma Blood Institute Northwest on December 2, 2011 in Enid, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 2, 2011
Fiscal Year
2012
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Enid, OK (United States)